go back

Hydroxyzine Pamoate, Oral

Oklahoma rates for HCPCS Q0177

Hydroxyzine pamoate, 25 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $1 · 10th–90th $0$10%10%20%10th90th$1Professionalmedian $0 · 10th–90th $0$00%50%10th90th$0$0.1$0.5$5.0$50.0$500.0$5.0K$50.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.12
Median
$0.12
Typical High
$0.24
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.12
Median
$0.12
Typical High
$0.13
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.52
Median
$0.79
Typical High
$1.32
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.15
Median
$0.15
Typical High
$0.20
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.13
Median
$0.13
Typical High
$0.13
Medica
Setting
Facility
Modifier
Global
Typical Low
$0.10
Median
$0.11
Typical High
$0.46
Medica
Setting
Professional
Modifier
Global
Typical Low
$0.10
Median
$0.10
Typical High
$61.66
United
Setting
Facility
Modifier
Global
Typical Low
$0.13
Median
$0.13
Typical High
$3.31
United
Setting
Professional
Modifier
Global
Typical Low
$0.12
Median
$0.13
Typical High
$0.13